<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1665-1146</journal-id>
<journal-title><![CDATA[Boletín médico del Hospital Infantil de México]]></journal-title>
<abbrev-journal-title><![CDATA[Bol. Med. Hosp. Infant. Mex.]]></abbrev-journal-title>
<issn>1665-1146</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1665-11462016000600432</article-id>
<article-id pub-id-type="doi">10.1016/j.bmhimx.2016.11.006</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Allergies: diseases closely related to cancer]]></article-title>
<article-title xml:lang="es"><![CDATA[Alergias: enfermedades estrechamente relacionadas con el cáncer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tirado-Rodríguez]]></surname>
<given-names><![CDATA[Belén]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Huerta-Yépez]]></surname>
<given-names><![CDATA[Sara]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,University of California Deparment of Pathology and Laboratory Medicine ]]></institution>
<addr-line><![CDATA[Los Angeles California]]></addr-line>
<country>USA</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Hospital Infantil de México Federico Gómez Unidad de Investigación en Enfermedades Oncológicas ]]></institution>
<addr-line><![CDATA[ Mexico City]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>73</volume>
<numero>6</numero>
<fpage>432</fpage>
<lpage>445</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1665-11462016000600432&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1665-11462016000600432&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1665-11462016000600432&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Allergies are hypersensitivity reactions that occur through specific type Th2 immunological mechanisms characterized by different soluble mediators, as well as specific cells of the immune system. In recent decades, evidence has emerged relating this disease with cancer development. However, most of the results of epidemiology studies have been controversial and contradictory. There are mainly two trends. While the first indicates that allergies can reduce the risk of cancer, the other indicates that they may increase this risk. The first trend can be explained by the immunosurveillance hypothesis, which states that the increased immune surveillance after the immune hyper-responsiveness can inhibit or exert a protective effect against the development of cancer. Similarly, the prophylaxis hypothesis suggests that the physical effects of allergy symptoms can prevent cancer by removing potential carcinogens. In contrast, the opposing hypothesis propose that there is a deviation of the immune response toward Th2, which favors the development of cancer, or that the process of chronic inflammation favors the generation of mutations, and therefore the development of cancer. With the purpose of understanding more about these two hypotheses, the main soluble and cellular factors of allergic diseases that could be playing a key role in the development or inhibition of cancer were considered in this review.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: Las alergias son reacciones de hipersensibilidad que ocurren mediante mecanismos inmunológicos específicos de tipo Th2. Se caracterizan por distintos mediadores solubles, así como células específicas del sistema inmune. En las últimas décadas ha surgido evidencia que asocia esta enfermedad con el desarrollo de cáncer. Sin embargo, los resultados obtenidos, en su mayoría de estudios epidemiológicos, han sido controversiales y contradictorios. Lo anterior se debe a que existen dos principales tendencias. Mientras algunos estudios han demostrado que las alergias pueden reducir el riesgo de cáncer, otros estudios muestran que puede aumentarlo. Lo primero puede explicarse por la hipótesis de inmunovigilancia, que establece que el aumento de la vigilancia después de la hiperreactividad inmune puede inhibir o ejercer un efecto protector contra el desarrollo de cáncer. Del mismo modo, la hipótesis de la profilaxis sugiere que los efectos físicos de síntomas de las alergias pueden prevenir el cáncer mediante la eliminación de los carcinógenos potenciales. Las hipótesis opuestas proponen que existe un desvío de la respuesta inmune hacia Th2 lo cual favorece el desarrollo del cáncer, o que el proceso de inflamación crónica favorece la generación de mutaciones, y por tanto el desarrollo del cáncer. Con el propósito de entender más acerca de estas dos hipótesis, en esta revisión se consideraron los principales factores solubles y celulares de las enfermedades alérgicas que pudieran estar desempeñando un papel clave en el desarrollo o inhibición del cáncer.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Alergias]]></kwd>
<kwd lng="es"><![CDATA[Cáncer]]></kwd>
<kwd lng="es"><![CDATA[Alergo-oncología]]></kwd>
<kwd lng="es"><![CDATA[TGF-&#946;]]></kwd>
<kwd lng="es"><![CDATA[IgE]]></kwd>
<kwd lng="es"><![CDATA[Mastocitos]]></kwd>
<kwd lng="en"><![CDATA[Allergies]]></kwd>
<kwd lng="en"><![CDATA[Cancer]]></kwd>
<kwd lng="en"><![CDATA[AllergoOncology]]></kwd>
<kwd lng="en"><![CDATA[TGF-&#946;]]></kwd>
<kwd lng="en"><![CDATA[IgE]]></kwd>
<kwd lng="en"><![CDATA[Mast cells]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Anaphylaxis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ring]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Grosber]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Brockow]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Bergmann]]></surname>
<given-names><![CDATA[K.C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Chem Immunol Allergy]]></source>
<year>2014</year>
<volume>100</volume>
<page-range>54-61</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Johansson]]></surname>
<given-names><![CDATA[S.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Bieber]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Dahl]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Friedmann]]></surname>
<given-names><![CDATA[P.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Lanier]]></surname>
<given-names><![CDATA[B.Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Lockey]]></surname>
<given-names><![CDATA[R.F.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Allergy Clin Immunol]]></source>
<year>2004</year>
<volume>113</volume>
<page-range>832-6</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Diagnosis and treatment of insect sensitivity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mueller]]></surname>
<given-names><![CDATA[H.L.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Asthma Res]]></source>
<year>1966</year>
<volume>3</volume>
<page-range>331-3</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[A.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Anzano]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Lamb]]></surname>
<given-names><![CDATA[L.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Sporn]]></surname>
<given-names><![CDATA[M.B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Proc Natl Acad Sci U S A]]></source>
<year>1981</year>
<volume>78</volume>
<page-range>5339-43</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[TGF-beta: an important mediator of allergic disease and a molecule with dual activity in cancer development]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tirado-Rodriguez]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Immunol Res]]></source>
<year>2014</year>
<volume>2014</volume>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kero]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Gissler]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Hemminki]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Isolauri]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Allergy Clin Immunol]]></source>
<year>2001</year>
<volume>108</volume>
<page-range>781-3</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simpson]]></surname>
<given-names><![CDATA[C.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[W.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Helms]]></surname>
<given-names><![CDATA[P.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[M.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Watson]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Prescott]]></surname>
<given-names><![CDATA[G.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Exp Allergy]]></source>
<year>2002</year>
<volume>32</volume>
<page-range>37-42</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Allergy-related diseases and cancer: an inverse association]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vena]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Bona]]></surname>
<given-names><![CDATA[J.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Byers]]></surname>
<given-names><![CDATA[T.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Middleton]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Swanson]]></surname>
<given-names><![CDATA[M.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Graham]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Epidemiol]]></source>
<year>1985</year>
<volume>122</volume>
<page-range>66-74</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heikkila]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Lowe]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Rumley]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Yarnell]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Gallacher]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Causes Control]]></source>
<year>2009</year>
<volume>20</volume>
<page-range>15-26</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Siemes]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Visser]]></surname>
<given-names><![CDATA[L.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Coebergh]]></surname>
<given-names><![CDATA[J.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Splinter]]></surname>
<given-names><![CDATA[T.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Witteman]]></surname>
<given-names><![CDATA[J.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Uitterlinden]]></surname>
<given-names><![CDATA[A.G.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Oncol]]></source>
<year>2006</year>
<volume>24</volume>
<page-range>5216-22</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The function of allergy: immunological defense against toxins]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Profet]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Q Rev Biol]]></source>
<year>1991</year>
<volume>66</volume>
<page-range>23-62</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Allergies: their role in cancer prevention]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sherman]]></surname>
<given-names><![CDATA[P.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Holland]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Sherman]]></surname>
<given-names><![CDATA[J.S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Q Rev Biol]]></source>
<year>2008</year>
<volume>83</volume>
<page-range>339-62</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Association between cancer and allergies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kozlowska]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Bozek]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Jarzab]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Allergy Asthma Clin Immunol]]></source>
<year>2016</year>
<volume>12</volume>
<page-range>39</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Transforming growth factor-beta2 induces bronchial epithelial mucin expression in asthma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[H.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Balzar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Seedorf]]></surname>
<given-names><![CDATA[G.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Westcott]]></surname>
<given-names><![CDATA[J.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Trudeau]]></surname>
<given-names><![CDATA[J.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Silkoff]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Pathol]]></source>
<year>2004</year>
<volume>165</volume>
<page-range>1097-106</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Airway epithelial cells from asthmatic children differentially express proremodeling factors]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lopez-Guisa]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Powers]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[File]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Cochrane]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Jimenez]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Debley]]></surname>
<given-names><![CDATA[J.S.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Allergy Clin Immunol]]></source>
<year>2012</year>
<volume>129</volume>
<page-range>990-7</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Increased TGF-beta2 in severe asthma with eosinophilia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balzar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[H.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Silkoff]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Cundall]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Trudeau]]></surname>
<given-names><![CDATA[J.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Strand]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Allergy Clin Immunol]]></source>
<year>2005</year>
<volume>115</volume>
<page-range>110-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[TGF-beta signaling in development and disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Massague]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[FEBS Lett]]></source>
<year>2012</year>
<volume>586</volume>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Angiogenesis and remodeling of airway vasculature in chronic inflammation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[McDonald]]></surname>
<given-names><![CDATA[D.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2001</year>
<volume>164</volume>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>S39-45</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The prognostic role of TGF-beta signaling pathway in breast cancer patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Kruijf]]></surname>
<given-names><![CDATA[E.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Dekker]]></surname>
<given-names><![CDATA[T.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Hawinkels]]></surname>
<given-names><![CDATA[L.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Putter]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Smit]]></surname>
<given-names><![CDATA[V.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Kroep]]></surname>
<given-names><![CDATA[J.R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Oncol]]></source>
<year>2013</year>
<volume>24</volume>
<page-range>384-90</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Induction of apoptosis in tumor cells as a mechanism of tumor growth reduction in allergic mice]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[F.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Menezes]]></surname>
<given-names><![CDATA[G.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Moura]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Cassali]]></surname>
<given-names><![CDATA[G.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[M.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Cara]]></surname>
<given-names><![CDATA[D.C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pathol Res Pract]]></source>
<year>2009</year>
<volume>205</volume>
<page-range>559-67</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[In vivo disruption of TGF-beta signaling by Smad7 in airway epithelium alleviates allergic asthma but aggravates lung carcinogenesis in mouse]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Ding]]></surname>
<given-names><![CDATA[Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Mao]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS One]]></source>
<year>2010</year>
<volume>5</volume>
</nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Inhibition of tumor progression during allergic airway inflammation in a murine model: significant role of TGF-beta]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tirado-Rodriguez]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Baay-Guzman]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez-Pando]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Antonio-Andres]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Vega]]></surname>
<given-names><![CDATA[M.I.]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha-Zavaleta]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Immunol Immunother]]></source>
<year>2015</year>
<volume>64</volume>
<page-range>1205-14</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Janeway]]></surname>
<given-names><![CDATA[C.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Tavers]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Walport]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Shlomchik]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Immunobiology: the immune system in health and disease]]></source>
<year>2005</year>
<page-range>367-406</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Garland Science Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kinet]]></surname>
<given-names><![CDATA[J.P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Annu Rev Immunol]]></source>
<year>1999</year>
<volume>17</volume>
<page-range>931-72</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The biology of IgE and the basis of allergic disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gould]]></surname>
<given-names><![CDATA[H.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Sutton]]></surname>
<given-names><![CDATA[B.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Beavil]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Beavil]]></surname>
<given-names><![CDATA[R.L.]]></given-names>
</name>
<name>
<surname><![CDATA[McCloskey]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Coker]]></surname>
<given-names><![CDATA[H.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Annu Rev Immunol]]></source>
<year>2003</year>
<volume>21</volume>
<page-range>579-628</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yokota]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Yukawa]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Yamamoto]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Sugiyama]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Suemura]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Tashiro]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<source><![CDATA[Proc Natl Acad Sci U S A]]></source>
<year>1992</year>
<volume>89</volume>
<page-range>5030-4</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[IgE in allergy and asthma today]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gould]]></surname>
<given-names><![CDATA[H.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Sutton]]></surname>
<given-names><![CDATA[B.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat Rev Immunol]]></source>
<year>2008</year>
<volume>8</volume>
<page-range>205-17</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karagiannis]]></surname>
<given-names><![CDATA[S.N.]]></given-names>
</name>
<name>
<surname><![CDATA[Josephs]]></surname>
<given-names><![CDATA[D.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Karagiannis]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Gilbert]]></surname>
<given-names><![CDATA[A.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Saul]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Rudman]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Immunol Immunother]]></source>
<year>2012</year>
<volume>61</volume>
<page-range>1547-64</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galli]]></surname>
<given-names><![CDATA[S.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Immunol]]></source>
<year>2010</year>
<volume>40</volume>
<page-range>1843-51</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ying]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[D.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Meng]]></surname>
<given-names><![CDATA[Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Barata]]></surname>
<given-names><![CDATA[L.T.]]></given-names>
</name>
<name>
<surname><![CDATA[McEuen]]></surname>
<given-names><![CDATA[A.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Buckley]]></surname>
<given-names><![CDATA[M.G.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Immunol]]></source>
<year>1999</year>
<volume>163</volume>
<page-range>3976-84</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[AllergoOncology: the role of IgE-mediated allergy in cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jensen-Jarolim]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Achatz]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Turner]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Karagiannis]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Legrand]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Capron]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Allergy]]></source>
<year>2008</year>
<volume>63</volume>
<page-range>1255-66</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Geohelminth infections: a review of the role of IgE and assessment of potential risks of anti-IgE treatment]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[P.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Ayre]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Rizzo]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ponte]]></surname>
<given-names><![CDATA[E.V.]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[A.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Allergy]]></source>
<year>2008</year>
<volume>63</volume>
<page-range>409-17</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[IgE: a question of protective immunity in Trichinella spiralis infection]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Watanabe]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Bruschi]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Korenaga]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Trends Parasitol]]></source>
<year>2005</year>
<volume>21</volume>
<page-range>175-8</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hardwick]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Chain]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Immunotherapy]]></source>
<year>2011</year>
<volume>3</volume>
<page-range>731-3</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The histamine H3 receptor: structure, pharmacology and function]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nieto-Alamilla]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Marquez-Gomez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Galvez]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Morales-Figueroa]]></surname>
<given-names><![CDATA[G.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Arias-Montano]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Mol Pharmacol]]></source>
<year>2016</year>
<volume>90</volume>
<page-range>649-73</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Animal sting and bites]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pastrana]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Blasco]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Erce]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Pinillos]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Anales Sis San Navarra]]></source>
<year>2003</year>
<volume>26</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>225-41</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Results of drug hypersensitivity evaluations in a large group of children and adults]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rubio]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Bousquet]]></surname>
<given-names><![CDATA[P.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Romano]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Demoly]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Exp Allergy]]></source>
<year>2012</year>
<volume>42</volume>
<page-range>123-30</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tumour-associated macrophages and cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cook]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Hagemann]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Opin Pharmacol]]></source>
<year>2013</year>
<volume>13</volume>
<page-range>595-601</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast cells: the Jekyll and Hyde of tumor growth]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Theoharides]]></surname>
<given-names><![CDATA[T.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Conti]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Trends Immunol]]></source>
<year>2004</year>
<volume>25</volume>
<page-range>235-41</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Fibroblasts induce epithelial to mesenchymal transition in breast tumor cells which is prevented by fibroblasts treatment with histamine in high concentration]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Porretti]]></surname>
<given-names><![CDATA[J.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Mohamad]]></surname>
<given-names><![CDATA[N.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[G.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Cricco]]></surname>
<given-names><![CDATA[G.P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Biochem Cell Biol]]></source>
<year>2014</year>
<volume>51</volume>
<page-range>29-38</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brune]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Castaigne]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Catalano]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Gehlsen]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[A.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Hofmann]]></surname>
<given-names><![CDATA[W.K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood]]></source>
<year>2006</year>
<volume>108</volume>
<page-range>88-96</page-range></nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Histamine as an adjunct to immunotherapy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naredi]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Semin Oncol]]></source>
<year>2002</year>
<volume>29</volume>
<numero>3^s7</numero>
<issue>3^s7</issue>
<supplement>7</supplement>
<page-range>31-4</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perz]]></surname>
<given-names><![CDATA[J.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[A.D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Future Oncol]]></source>
<year>2008</year>
<volume>4</volume>
<page-range>169-77</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Histamine dihydrochloride: in the management of acute myeloid leukaemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[L.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Perry]]></surname>
<given-names><![CDATA[C.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Drugs]]></source>
<year>2011</year>
<volume>71</volume>
<page-range>109-22</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Histamine inhibits cell proliferation and modulates the expression of Bcl-2 family proteins via the H2 receptor in human pancreatic cancer cells]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cricco]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Nunez]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mohamad]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Croci]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Anticancer Res]]></source>
<year>2006</year>
<volume>26</volume>
<page-range>4443-50</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Histamine-mediated signaling processes in human malignant mammary cells]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Cricco]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Nunez]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Mohamad]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Correa-Fiz]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Biol Ther]]></source>
<year>2006</year>
<volume>5</volume>
<page-range>1462-71</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast cell progenitors: origin, development and migration to tissues]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dahlin]]></surname>
<given-names><![CDATA[J.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Hallgren]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Mol Immunol]]></source>
<year>2015</year>
<volume>63</volume>
<page-range>9-17</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast cell heterogeneity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Irani]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[L.B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Exp Allergy]]></source>
<year>1989</year>
<volume>19</volume>
<page-range>143-55</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Human mast cell heterogeneity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Irani]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[L.B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Allergy Proc]]></source>
<year>1994</year>
<volume>15</volume>
<page-range>303-8</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Human endothelial cells regulate survival and proliferation of human mast cells]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mierke]]></surname>
<given-names><![CDATA[C.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Ballmaier]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Werner]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Manns]]></surname>
<given-names><![CDATA[M.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Welte]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Bischoff]]></surname>
<given-names><![CDATA[S.C.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Exp Med]]></source>
<year>2000</year>
<volume>192</volume>
<page-range>801-11</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast-cell infiltration of airway smooth muscle in asthma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brightling]]></surname>
<given-names><![CDATA[C.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Bradding]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Symon]]></surname>
<given-names><![CDATA[F.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Holgate]]></surname>
<given-names><![CDATA[S.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Wardlaw]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Pavord]]></surname>
<given-names><![CDATA[I.D.]]></given-names>
</name>
</person-group>
<source><![CDATA[N Engl J Med]]></source>
<year>2002</year>
<volume>346</volume>
<page-range>1699-705</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furuta]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Imajo-Ohmi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Fukuda]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Kano]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Miyake]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Watanabe]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Immunol]]></source>
<year>2008</year>
<volume>38</volume>
<page-range>1341-50</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hassan]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Kinoshita]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Kawanami]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Kishi]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Matsushima]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Ohashi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Dig Dis Sci]]></source>
<year>1998</year>
<volume>43</volume>
<page-range>8-14</page-range></nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patruno]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Marech]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Zizzo]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Ammendola]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Nardulli]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Gadaleta]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Biomed Res Int]]></source>
<year>2014</year>
<volume>2014</volume>
</nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The mast cell: an evolutionary perspective]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crivellato]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Ribatti]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Biol Rev Camb Philos Soc]]></source>
<year>2010</year>
<volume>85</volume>
<page-range>347-60</page-range></nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mangia]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Malfettone]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Paradiso]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ranieri]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Simone]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Histopathology]]></source>
<year>2011</year>
<volume>58</volume>
<page-range>1096-106</page-range></nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prognostic value of tumor-infiltrating mast cells in outcome of patients with esophagus squamous cell carcinoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fakhrjou]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Niroumand-Oscoei]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Somi]]></surname>
<given-names><![CDATA[M.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Ghojazadeh]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Naghashi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Samankan]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Gastrointest Cancer]]></source>
<year>2014</year>
<volume>45</volume>
<page-range>48-53</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The role of mast cells in cancers]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maciel]]></surname>
<given-names><![CDATA[T.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Moura]]></surname>
<given-names><![CDATA[I.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Hermine]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
</person-group>
<source><![CDATA[F1000Prime Rep]]></source>
<year>2015</year>
<volume>7</volume>
</nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ribatti]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Immunology Lett]]></source>
<year>2013</year>
<volume>152</volume>
<page-range>83-8</page-range></nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[D.Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Ji]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Deng]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Cancer Res]]></source>
<year>2011</year>
<volume>17</volume>
<page-range>7015-23</page-range></nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast cells and cancer: enemies or allies?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dyduch]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Kaczmarczyk]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Okon]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pol J Pathol]]></source>
<year>2012</year>
<volume>63</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The significant role of mast cells in cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khazaie]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Blatner]]></surname>
<given-names><![CDATA[N.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[M.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Gounari]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Gounaris]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Dennis]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Metastasis Rev]]></source>
<year>2011</year>
<volume>30</volume>
<page-range>45-60</page-range></nlm-citation>
</ref>
<ref id="B63">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Visciano]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Liotti]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Prevete]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Cali]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Franco]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Collina]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Oncogene]]></source>
<year>2015</year>
<volume>34</volume>
<page-range>5175-86</page-range></nlm-citation>
</ref>
<ref id="B64">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mast cells as regulators of adaptive immunity to tumours]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wasiuk]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[de Vries]]></surname>
<given-names><![CDATA[V.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Hartmann]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Roers]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Noelle]]></surname>
<given-names><![CDATA[R.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Exp Immunol]]></source>
<year>2009</year>
<volume>155</volume>
<page-range>140-6</page-range></nlm-citation>
</ref>
<ref id="B65">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The eosinophil]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rothenberg]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Hogan]]></surname>
<given-names><![CDATA[S.P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Annu Rev Immunol]]></source>
<year>2006</year>
<volume>24</volume>
<page-range>147-74</page-range></nlm-citation>
</ref>
<ref id="B66">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Eosinophils: changing perspectives in health and disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosenberg]]></surname>
<given-names><![CDATA[H.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Dyer]]></surname>
<given-names><![CDATA[K.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Foster]]></surname>
<given-names><![CDATA[P.S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat Rev Immunol]]></source>
<year>2013</year>
<volume>13</volume>
<page-range>9-22</page-range></nlm-citation>
</ref>
<ref id="B67">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lopez-Lago]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Posner]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Thodima]]></surname>
<given-names><![CDATA[V.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Motzer]]></surname>
<given-names><![CDATA[R.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Chaganti]]></surname>
<given-names><![CDATA[R.S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Oncogene]]></source>
<year>2013</year>
<volume>32</volume>
<page-range>1752-60</page-range></nlm-citation>
</ref>
<ref id="B68">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Eosinophilia in dermatologic disorders]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Graauw]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Beltraminelli]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[H.U.]]></given-names>
</name>
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Immunol Allergy Clin North Am]]></source>
<year>2015</year>
<volume>35</volume>
<page-range>545-60</page-range></nlm-citation>
</ref>
<ref id="B69">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Th2-mediated anti-tumour immunity: friend or foe?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ellyard]]></surname>
<given-names><![CDATA[J.I.]]></given-names>
</name>
<name>
<surname><![CDATA[Simson]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Parish]]></surname>
<given-names><![CDATA[C.R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Tissue Antigens]]></source>
<year>2007</year>
<volume>70</volume>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B70">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Eosinophils: multifaceted biological properties and roles in health and disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kita]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Immunological Rev]]></source>
<year>2011</year>
<volume>242</volume>
<page-range>161-77</page-range></nlm-citation>
</ref>
<ref id="B71">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lotfi]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Lotze]]></surname>
<given-names><![CDATA[M.T.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Immunother]]></source>
<year>2007</year>
<volume>30</volume>
<page-range>16-28</page-range></nlm-citation>
</ref>
<ref id="B72">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carretero]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Sektioglu]]></surname>
<given-names><![CDATA[I.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Garbi]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Salgado]]></surname>
<given-names><![CDATA[O.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Beckhove]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Hammerling]]></surname>
<given-names><![CDATA[G.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature Immunol]]></source>
<year>2015</year>
<volume>16</volume>
<page-range>609-17</page-range></nlm-citation>
</ref>
<ref id="B73">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Involvement of eosinophils in the anti-tumor response]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gatault]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Legrand]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Delbeke]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Loiseau]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Capron]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Immunol Immunother]]></source>
<year>2012</year>
<volume>61</volume>
<page-range>1527-34</page-range></nlm-citation>
</ref>
<ref id="B74">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[van Driel]]></surname>
<given-names><![CDATA[W.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kievit-Tyson]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[van den Broek]]></surname>
<given-names><![CDATA[L.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Zwinderman]]></surname>
<given-names><![CDATA[A.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Trimbos]]></surname>
<given-names><![CDATA[B.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Fleuren]]></surname>
<given-names><![CDATA[G.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Gynecol Oncol]]></source>
<year>1999</year>
<volume>74</volume>
<page-range>188-95</page-range></nlm-citation>
</ref>
<ref id="B75">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The role of eosinophils in the pathobiology of Hodgkin's disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Aldinucci]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Gloghini]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Zagonel]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Degan]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Perin]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Oncol]]></source>
<year>1997</year>
<volume>8</volume>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>89-96</page-range></nlm-citation>
</ref>
<ref id="B76">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iwasaki]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Torisu]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Fujimura]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer]]></source>
<year>1986</year>
<volume>58</volume>
<page-range>1321-7</page-range></nlm-citation>
</ref>
<ref id="B77">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lotfi]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Herzog]]></surname>
<given-names><![CDATA[G.I.]]></given-names>
</name>
<name>
<surname><![CDATA[DeMarco]]></surname>
<given-names><![CDATA[R.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Beer-Stolz]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Rubartelli]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Immunol]]></source>
<year>2009</year>
<volume>183</volume>
<page-range>5023-31</page-range></nlm-citation>
</ref>
<ref id="B78">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gibbs]]></surname>
<given-names><![CDATA[B.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Haas]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Falcone]]></surname>
<given-names><![CDATA[F.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Albrecht]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Vollrath]]></surname>
<given-names><![CDATA[I.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Noll]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Immunol]]></source>
<year>1996</year>
<volume>26</volume>
<page-range>2493-8</page-range></nlm-citation>
</ref>
<ref id="B79">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Diagnostic tests based on human basophils: potentials, pitfalls and perspectives]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kleine-Tebbe]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Erdmann]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Knol]]></surname>
<given-names><![CDATA[E.F.]]></given-names>
</name>
<name>
<surname><![CDATA[MacGlashan]]></surname>
<given-names><![CDATA[D.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Poulsen]]></surname>
<given-names><![CDATA[L.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Gibbs]]></surname>
<given-names><![CDATA[B.F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Int Arch Allergy Immunol]]></source>
<year>2006</year>
<volume>141</volume>
<page-range>79-90</page-range></nlm-citation>
</ref>
<ref id="B80">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Human basophils: mediator release and cytokine production]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schroeder]]></surname>
<given-names><![CDATA[J.T.]]></given-names>
</name>
<name>
<surname><![CDATA[MacGlashan]]></surname>
<given-names><![CDATA[D.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Lichtenstein]]></surname>
<given-names><![CDATA[L.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Adv Immunol]]></source>
<year>2001</year>
<volume>77</volume>
<page-range>93-122</page-range></nlm-citation>
</ref>
<ref id="B81">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Emerging functions of basophils in protective and allergic immune responses]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sokol]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Medzhitov]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Mucosal Immunol]]></source>
<year>2010</year>
<volume>3</volume>
<page-range>129-37</page-range></nlm-citation>
</ref>
<ref id="B82">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yoshimoto]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Yasuda]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Nakahira]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Imai]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Fujimori]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat Immunol]]></source>
<year>2009</year>
<volume>10</volume>
<page-range>706-12</page-range></nlm-citation>
</ref>
<ref id="B83">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Transendothelial migration of human basophils]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iikura]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ebisawa]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Yamaguchi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Tachimoto]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Ohta]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Yamamoto]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Immunol]]></source>
<year>2004</year>
<volume>173</volume>
<page-range>5189-95</page-range></nlm-citation>
</ref>
<ref id="B84">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uguccioni]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mackay]]></surname>
<given-names><![CDATA[C.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Ochensberger]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Loetscher]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Rhis]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[LaRosa]]></surname>
<given-names><![CDATA[G.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Invest]]></source>
<year>1997</year>
<volume>100</volume>
<page-range>1137-43</page-range></nlm-citation>
</ref>
<ref id="B85">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bochner]]></surname>
<given-names><![CDATA[B.S.]]></given-names>
</name>
<name>
<surname><![CDATA[McKelvey]]></surname>
<given-names><![CDATA[A.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Sterbinsky]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hildreth]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Derse]]></surname>
<given-names><![CDATA[C.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Klunk]]></surname>
<given-names><![CDATA[D.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Immunol]]></source>
<year>1990</year>
<volume>145</volume>
<page-range>1832-7</page-range></nlm-citation>
</ref>
<ref id="B86">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Regulation and kinetics of platelet-activating factor and leukotriene C4 synthesis by activated human basophils]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lie]]></surname>
<given-names><![CDATA[W.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Homburg]]></surname>
<given-names><![CDATA[C.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Kuijpers]]></surname>
<given-names><![CDATA[T.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Knol]]></surname>
<given-names><![CDATA[E.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Mul]]></surname>
<given-names><![CDATA[F.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Roos]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Exp Allergy]]></source>
<year>2003</year>
<volume>33</volume>
<page-range>1125-34</page-range></nlm-citation>
</ref>
<ref id="B87">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Siracusa]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Saenz]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hill]]></surname>
<given-names><![CDATA[D.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[B.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Headley]]></surname>
<given-names><![CDATA[M.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Doering]]></surname>
<given-names><![CDATA[T.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature]]></source>
<year>2011</year>
<volume>477</volume>
<page-range>229-33</page-range></nlm-citation>
</ref>
<ref id="B88">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Innate immune cell populations function as initiators and effectors in Th2 cytokine responses]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saenz]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Noti]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Artis]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Trends Immunol]]></source>
<year>2010</year>
<volume>31</volume>
<page-range>407-13</page-range></nlm-citation>
</ref>
<ref id="B89">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[MacGlashan]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[S.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Ono]]></surname>
<given-names><![CDATA[S.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Schroeder]]></surname>
<given-names><![CDATA[J.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Lichtenstein]]></surname>
<given-names><![CDATA[L.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Immunol]]></source>
<year>1994</year>
<volume>152</volume>
<page-range>3006-16</page-range></nlm-citation>
</ref>
<ref id="B90">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Min]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Prout]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Hu-Li]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Jankovic]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Morgan]]></surname>
<given-names><![CDATA[E.S.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Exp Med]]></source>
<year>2004</year>
<volume>200</volume>
<page-range>507-17</page-range></nlm-citation>
</ref>
<ref id="B91">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Min]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Immunol]]></source>
<year>2009</year>
<volume>183</volume>
<page-range>3033-9</page-range></nlm-citation>
</ref>
<ref id="B92">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perrigoue]]></surname>
<given-names><![CDATA[J.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Saenz]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Siracusa]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Allenspach]]></surname>
<given-names><![CDATA[E.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[B.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Giacomin]]></surname>
<given-names><![CDATA[P.R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat Immunol]]></source>
<year>2009</year>
<volume>10</volume>
<page-range>697-705</page-range></nlm-citation>
</ref>
<ref id="B93">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Basophil recruitment into tumor-draining lymph nodes correlates with Th2 inflammation and reduced survival in pancreatic cancer patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Monte]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Wormann]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Brunetto]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Heltai]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Magliacane]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Reni]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Res]]></source>
<year>2016</year>
<volume>76</volume>
<page-range>1792-803</page-range></nlm-citation>
</ref>
<ref id="B94">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progression]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cerny-Reiterer]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Ghanim]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Hoermann]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Aichberger]]></surname>
<given-names><![CDATA[K.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Herrmann]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Muellauer]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neoplasia]]></source>
<year>2012</year>
<volume>14</volume>
<page-range>572-84</page-range></nlm-citation>
</ref>
<ref id="B95">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Chronic myelogenous leukemia with mild basophilia as the predominant manifestation at presentation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yasuda]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Aritaka]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Ando]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Hirama]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Komatsu]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Hirano]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Intern Med]]></source>
<year>2011</year>
<volume>50</volume>
<page-range>501-2</page-range></nlm-citation>
</ref>
<ref id="B96">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Dysplastic basophils in the accelerated phase of chronic myelogenous leukemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bain]]></surname>
<given-names><![CDATA[B.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Heller]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Hematol]]></source>
<year>2011</year>
<volume>86</volume>
</nlm-citation>
</ref>
<ref id="B97">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Flow cytometric detection of degranulated basophils in chronic myeloid leukemia in accelerated phase]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stacchini]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Demurtas]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Godio]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cytometry B Clin Cytom]]></source>
<year>2011</year>
<volume>80</volume>
<page-range>122-4</page-range></nlm-citation>
</ref>
<ref id="B98">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wimazal]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Germing]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Kundi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Noesslinger]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Blum]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Geissler]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer]]></source>
<year>2010</year>
<volume>116</volume>
<page-range>2372-81</page-range></nlm-citation>
</ref>
<ref id="B99">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[On the dual roles and polarized phenotypes of neutrophils in tumor development and progression]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piccard]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Muschel]]></surname>
<given-names><![CDATA[R.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Opdenakker]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Crit Rev Oncol Hematol]]></source>
<year>2012</year>
<volume>82</volume>
<page-range>296-309</page-range></nlm-citation>
</ref>
<ref id="B100">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Protumor and antitumor functions of neutrophil granulocytes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brandau]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Dumitru]]></surname>
<given-names><![CDATA[C.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Semin Immunopathol]]></source>
<year>2013</year>
<volume>35</volume>
<page-range>163-76</page-range></nlm-citation>
</ref>
<ref id="B101">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dumitru]]></surname>
<given-names><![CDATA[C.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Brandau]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Semin Cancer Biol]]></source>
<year>2013</year>
<volume>23</volume>
<page-range>141-8</page-range></nlm-citation>
</ref>
<ref id="B102">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Granulocytes as effective anticancer agent in experimental solid tumor models]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jaganjac]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Poljak-Blazi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Kirac]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Borovic]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Joerg Schaur]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Zarkovic]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<source><![CDATA[Immunobiology]]></source>
<year>2010</year>
<volume>215</volume>
<page-range>1015-20</page-range></nlm-citation>
</ref>
<ref id="B103">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kloecker]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Fleming]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bousamra 2nd]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Hansen]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
</person-group>
<source><![CDATA[Oncoimmunology]]></source>
<year>2014</year>
<volume>3</volume>
</nlm-citation>
</ref>
<ref id="B104">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Activated neutrophils exert antitumor activity against human melanoma cells: reactive oxygen species-induced mechanisms and their modulation by granulocyte-macrophage-colony-stimulating factor]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dissemond]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Weimann]]></surname>
<given-names><![CDATA[T.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[L.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Schneeberger]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Scharffetter-Kochanek]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Goos]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Invest Dermatol]]></source>
<year>2003</year>
<volume>121</volume>
<page-range>936-8</page-range></nlm-citation>
</ref>
<ref id="B105">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tumor entrained neutrophils inhibit seeding in the premetastatic lung]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Granot]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Henke]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Comen]]></surname>
<given-names><![CDATA[E.A.]]></given-names>
</name>
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[T.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Norton]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Benezra]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Cell]]></source>
<year>2011</year>
<volume>20</volume>
<page-range>300-14</page-range></nlm-citation>
</ref>
<ref id="B106">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Satpathy]]></surname>
<given-names><![CDATA[S.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Jala]]></surname>
<given-names><![CDATA[V.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Bodduluri]]></surname>
<given-names><![CDATA[S.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Krishnan]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Hegde]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Hoyle]]></surname>
<given-names><![CDATA[G.W.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat Commun]]></source>
<year>2015</year>
<volume>6</volume>
</nlm-citation>
</ref>
<ref id="B107">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gong]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Cumpian]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Caetano]]></surname>
<given-names><![CDATA[M.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa]]></surname>
<given-names><![CDATA[C.E.]]></given-names>
</name>
<name>
<surname><![CDATA[De la Garza]]></surname>
<given-names><![CDATA[M.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lapid]]></surname>
<given-names><![CDATA[D.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Mol Cancer]]></source>
<year>2013</year>
<volume>12</volume>
</nlm-citation>
</ref>
<ref id="B108">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Houghton]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rzymkiewicz]]></surname>
<given-names><![CDATA[D.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ji]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Gregory]]></surname>
<given-names><![CDATA[A.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Egea]]></surname>
<given-names><![CDATA[E.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Metz]]></surname>
<given-names><![CDATA[H.E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat Medicine]]></source>
<year>2010</year>
<volume>16</volume>
<page-range>219-23</page-range></nlm-citation>
</ref>
<ref id="B109">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hattar]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Franz]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Ludwig]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Sibelius]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Wilhelm]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Lohmeyer]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Immunol Immunother]]></source>
<year>2014</year>
<volume>63</volume>
<page-range>1297-306</page-range></nlm-citation>
</ref>
<ref id="B110">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grosse-Steffen]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Giese]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Giese]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Longerich]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Schirmacher]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Hansch]]></surname>
<given-names><![CDATA[G.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Dev Immunol]]></source>
<year>2012</year>
<volume>2012</volume>
</nlm-citation>
</ref>
<ref id="B111">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Yeh]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Oncotarget]]></source>
<year>2015</year>
<volume>6</volume>
<page-range>43081-9</page-range></nlm-citation>
</ref>
<ref id="B112">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2alpha and estrogen receptor beta signals]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Yeh]]></surname>
<given-names><![CDATA[C.R.]]></given-names>
</name>
<name>
<surname><![CDATA[He]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Pang]]></surname>
<given-names><![CDATA[S.T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Oncotarget]]></source>
<year>2015</year>
<volume>6</volume>
<page-range>19290-304</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
